Sun Pharma's Mr. Dilip Shanghvi invested in BioLight

Mr. Dilip Shanghvi, CEO of Sun Pharmaceuticals Industries Ltd has invested NIS 10.5M in Israel-based BioLight Israeli Life Sciences Investments Limited, for an 11% stake through his private company, MJ Pharmaceuticals Limited.

Link to comlete article (Hebrew) 

More News/Information